Leaders of Management Committee of Anhui Huangshan high tech Industrial Development Zone Visited Jiangsu SXT Pharmaceutical Co., Ltd

Jin Tao, Secretary of the Party committee of Huangshan high tech Zone, shakes hands with Zhou Feng, chairman of Jiangsu SXT pharmaceutical and Zheng Jun, executive director.On June 5, Jin Tao, Secreta......

Employee activity-Tug-of-war

Ms. Chai was warming up this competitionThe spirit of tug-of war The spirit of united heart, virtue and strengthTeam spirit is the concentrated embodiment of overall situation consciousness, coop......

Labor Day: Salute the extraordinary people in the ordinary post

In this world,There are thousands of ordinary people's stories on stage every dayThey live in all walks of life,Some in front of the stage, some behind the scenes,Some we often see,Some of them ha......

China SXT Pharmaceuticals, Inc. Announces Pricing of a $15 Million PIPE Financing

TAIZHOU, China, April 17, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company......

China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification

TAIZHOU, China, Apr. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the rese......

China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018

TAIZHOU, China, March 28, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the re......

China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering

TAIZHOU, China and NEW YORK, Jan. 4, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ: SXTC), a specialty pharmaceutical company foc......

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

TAIZHOU, China and New York, Jan. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc.  (the "Company") (NASDAQ:SXTC), a specialty pharmaceutical company foc......

China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share

TAIZHOU, China, Sept. 28, 2018 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the "Company"), a specialty pharmaceutical company focusing on the research, development, manuf......